Outlook Therapeutics- Warrants Current Assets

As of the most recent data (June 2026), OTLKW shows a current assets of $11M. That compares with $21T in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OTLKW's current assets is now $11M (was $21T) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Outlook Therapeutics- Warrants is outperforming or lagging.

Tracking OTLKW's current assets over time shows whether Outlook Therapeutics- Warrants is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $21T in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Outlook Therapeutics- Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $11M) with ownership activity and broader fundamentals.

Outlook Therapeutics- Warrants's current assets is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.